Condition
Depressive Disorder clinical trials and research
As of November 12, 2026, Find a Trial lists 45 Depressive Disorder clinical trials that are recruiting, at sites in 18 countries (most in United States (11), China (6), Canada (3)). 1 was first registered in the last 30 days. By phase: Phase 2 (5), Phase 1/2 (1). There are also 27 NIH-funded research projects on Depressive Disorder, with $14.6 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 45Clinical trials
- 27NIH research projects
- 1New in 30 days
- 18Countries
Newest Depressive Disorder clinical trials
All recruiting trials (45)
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Aerobic Exercise as an Adjunct Therapy for Depression
This study tests whether adding a structured aerobic exercise program to standard antidepressant and therapy helps reduce depression severity more than standard care alone.
-
Group Unified Protocol for Emotional Disorders in adults in public mental health (UP in Spanish)
A group-based Spanish version of the Unified Protocol is being tested with adults in public mental health to see if it helps anxiety, depression, and related symptoms.
-
Metformin added to antidepressants for depression with obesity in Pakistani adults
This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.
-
Parent group program using the Unified Protocol for teens with autism and anxiety/depression
This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.
-
Mindfulness‑augmented brain stimulation for treatment‑resistant depression
This trial will test whether combining fast brain stimulation (iTBS) with a digital mindfulness program helps people with treatment‑resistant depression reduce symptoms and improve thinking.
-
Digital stepped-care mindfulness program for emotional disorders
This project tests whether adding an online mindfulness program to usual care helps adults (18–65) with depression, anxiety, OCD, or PTSD recover faster and stay well longer.
-
Transcutaneous auricular vagus nerve stimulation for depression after heart procedures
This study tests whether at-home taVNS can help reduce depressive symptoms in adults 18–80 who recently had PCI for ACS.
-
Breathing practices to improve brain and mental health in adolescents
This project will try a structured breathing program to see if it helps adolescents aged 12–17 who are being treated for anxiety or mild to moderate depression.
-
Mapping complex cognitive problems across psychiatric and neurological conditions
This project will test a set of cognitive tests and optional brain recordings in adults with psychiatric or neurological disorders and healthy volunteers to map high-level thinking problems and how they change over time.
-
How mental health relates to immunotherapy response in triple-negative breast cancer
This project tries to see if a patient's mental health affects how well pre-surgery immunotherapy works for people with early triple-negative breast cancer.
-
Step-by-step care plan to improve treatment for moderate depression in general practice
It tests whether a structured step-by-step care plan used by general practitioners works better than usual GP care or psychologist-led behavioral therapy for adults 18–65 with moderate depression.
-
Gut microbiome and metabolites in people with IBD and depression
This project will test whether gut microbes and metabolites differ in adults with IBD who have depression compared with those without depression and with healthy adults.
-
Accelerated intermittent theta-burst stimulation for depression with post‑COVID‑19 condition
This will test whether two different schedules of intermittent theta-burst stimulation (accelerated TMS) reduce depressive symptoms and inflammation in adults aged 18–65 who have depressive disorder plus post‑COVID‑19 condition.
-
Temporal interference stimulation for depressive disorder
This test tries to see if temporal interference stimulation (TIS) can improve associative memory in adults with depressive disorder.
-
Developing a gamified app to help 8–12-year-olds with depression manage everyday stressors
This project will ask children ages 8–12 with increased depressive symptoms and their parents about daily stressors and coping to help design a gamified app that tries to teach emotion regulation.
-
Comparing brief psychoanalytic and emotionally focused couple therapies for relationship distress
This trial will test whether brief psychoanalytic couple therapy or emotionally focused therapy better reduces relationship problems and related depression and anxiety in heterosexual couples with moderate to severe relationship distress.
-
Personalized online program with human support for women with depression
A 3D 10-week online CBT program with weekly modules and six coaching sessions is tested as an add-on to usual care to see if it reduces depressive symptoms in women aged 18–45 with moderate depression.
-
Personalized lifestyle support with an app for adults seeing their GP for depression symptoms
This study tests whether a smartphone app that supports personalized lifestyle changes can help reduce depression symptoms for adults who visit their GP.
-
Non-invasive ear (auricular) vagus nerve stimulation for depression
This study will test whether non-invasive ear (auricular) vagus nerve stimulation helps adults with major depressive or bipolar depressive episodes and which biological markers change with treatment.
-
EL-SHIN: lavender, gratitude, fasting with exercise and light therapy for depressive symptoms
This trial will see if EL-SHIN—a combined lavender, gratitude, and fasting plus exercise and light therapy program—can help English-speaking adults with moderate depressive, anxiety, and stress symptoms.
-
Synbiotic supplement to improve mood and gut health in adults with obesity
This study will test whether taking a daily synbiotic (prebiotics plus beneficial bacteria) helps mood, gut microbiota, inflammation, appetite, and metabolic markers in adults with obesity who do or do not have anxiety or depression.
-
Using Psilocybe Cubensis Mushrooms with or without Fluoxetine for Treatment-Resistant Depression
This study is testing if taking Psilocybe cubensis mushrooms with or without fluoxetine can help people with treatment-resistant depression feel better.
-
Exploring body awareness in individuals with depressive disorders
This study is trying to see how aware people with depression are of their bodies and how this awareness might change during their hospital stay.
-
Comparing Islamic and Standard Hypnotherapy for Anxiety and Depression
This study is testing whether a special type of hypnotherapy that incorporates Islamic principles can help Muslim adults with anxiety and depression feel better compared to standard hypnotherapy.
-
Music therapy for teens with emotional challenges
This study tests if a music therapy program can help teenagers aged 13-18 who are dealing with depression and anxiety feel better.
-
Internet-based treatment for anxiety and depression in adolescents
This study is testing an online treatment for anxiety and depression in Romanian teenagers aged 13-17 to see if it helps them feel better and to find out which teens are most likely to benefit from it.
-
Testing a new drug for treatment-resistant depression
This study is testing a new drug called HNK to see if it can help people with treatment-resistant depression feel better when other medications haven't worked.
-
A program to help young adults from minority groups engage with mental health services
This study is testing a new program designed to help young adults from minority backgrounds connect better with mental health services by adding cultural insights and creative arts therapy.
-
Investigating the effects of citalopram on brain response to emotions
This study tests how the antidepressant citalopram affects the brain's response to emotions in healthy people by comparing brain scans after taking the medication or a placebo.
-
A platform for collecting data on mood disorders
This study is trying to create a better way to collect information from people with mood disorders like depression and bipolar disorder to help find new treatments that work for them.
-
Oh Happy Day Class – Digital Connections for Depression in African Americans
A mobile app delivers six weekly depression-therapy classes to African American adults to see if it helps reduce depressive symptoms.
-
Using brain stimulation to treat depression in older adults
This study is testing if a brain stimulation treatment can help older adults with depression who haven't found relief from regular medications.
-
Testing psilocybin's effects on brain activity in depression
This study is testing if psilocybin can change brain activity linked to mood in people with major depression to see if it helps them feel better.
-
Community Connections for treating emotional disorders in youth
This study is testing a new therapy program for kids and teens with anxiety and depression to see if it helps them feel better, and it involves both the youth and their parents.
-
Evaluating Ketamine Treatment Plans for Chronic Conditions
This study is testing different ways to use Ketamine for people with chronic pain, depression, and anxiety to see how well it works and if combining it with therapies like talk therapy or music helps improve their conditions.
-
Modified Dialectical Behavior Therapy for Treating Anxiety and Depression
This study is testing a new type of therapy called modified Dialectical Behavior Therapy to see if it can help people with anxiety and depression feel better and improve their quality of life.
-
Developing a group treatment to help teens at risk for serious mental illness
This study is testing a new group program to help high school students with mild signs of depression or anxiety build resilience and prevent serious mental health issues.
-
Psychotherapy to improve brain function and reduce suicidality in older adults
This study is testing a new therapy called Engage & Connect to see if it can help older adults with depression and suicidal thoughts by improving their brain function and encouraging social connections.
-
Predicting mood episode recurrence in bipolar and depressive disorders
A wearable-based study to see if heart rate, sleep, activity, and mood data from a smartwatch can help predict when manic or depressive episodes will come back in people with bipolar or depressive disorders.
-
Examining how AMPA receptor blockade affects Ketamine's ability to reduce suicidal thoughts
This study is testing if a medication called perampanel can improve the effects of Ketamine in reducing suicidal thoughts and depression in people with major depressive disorder, bipolar disorder, or PTSD.
-
OSU6162 for patients with depression not helped by standard treatments
This study is testing if a new medication called OSU6162 can help people with depression who haven't found relief from standard treatments.
-
Understanding children's emotions in therapy
This study is testing a new therapy approach for kids aged 8 to 15 with anxiety, depression, trauma, or behavior issues to see if it helps them feel better compared to those who aren't receiving treatment right away.
-
Cognitive-behavioral therapy and exercise training for teenage girls at risk for type 2 diabetes
This study is testing if cognitive-behavioral therapy, exercise training, or both can help teenage girls at risk for type 2 diabetes improve their health and reduce stress and depression.
-
Evaluating the effects of electroconvulsive therapy on depression
This study is testing how electroconvulsive therapy can help people with major depression feel better and what effects it might have on their thinking over six months.
NIH-funded research (27)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Psilocybin-Assisted ACT for Co-Occurring Cocaine Use Disorder and Major Depressive Disorder
A new treatment combines psilocybin with Acceptance and Commitment Therapy to help people who have both cocaine use disorder and major depressive disorder.
-
Single-cell study of mood-regulation brain circuits in depression
A large study will map which genes and cell types in mood-related brain circuits are linked to major depressive disorder, including differences by ancestry and sex.
-
Single-cell map of mood circuits in major depressive disorder
Researchers will map the tiny brain cells in mood-control areas to understand how genes and cell types relate to depression, with attention to ancestry and sex.
-
Making genetic research clearer to find genes linked to major depression
Researchers will use health records and genetic data to pinpoint genes that drive major depression, aiming to help people with depression get better-targeted treatments.
-
How iTBS and a brain drug could boost brain wiring to help depression
A study tests whether a brain-stimulating treatment (iTBS) works by improving brain plasticity and whether adding a drug (DCS) enhances this effect for people with major depressive disorder.
-
Portable, low-cost genetic test to guide antidepressant choices
This project is creating a small, affordable device that rapidly reads genes that affect how people with major depressive disorder process antidepressants to help choose safer, more effective medicines.
-
Psilocybin paired with cognitive behavioral therapy for adults with depression
This project combines two supervised psilocybin sessions with 12 sessions of cognitive behavioral therapy for adults living with major depressive disorder.
-
Genetic subtypes of major depression
This project looks at whether people with major depression can be grouped by their genetics to better understand different forms of the condition for people of different ages and ancestries.
-
Mapping cell and gene changes in the brain linked to depression
Mapping genes and cell types in key mood-regulating brain regions from people with major depressive disorder, including diverse ancestries and both sexes.
-
Single-cell map of mood-regulating brain regions in depression
Researchers will make a detailed cellular map of key brain areas that control mood to find molecular changes linked to major depression and how these vary by ancestry and sex.
-
A portable system for quick genetic testing in patients with major depression
This study is working on a handy, affordable tool that helps quickly check how your genes might affect how well certain depression medications work for you, so you can get the right treatment faster and with fewer side effects.
-
Investigating the role of VGF in Alzheimer's disease and depression
This study is looking at how late-onset Alzheimer's disease and depression are connected, focusing on a protein called VGF that might play a role in both, to help find better ways to treat these conditions.
-
How inflammation affects the brain in people with major depressive disorder
This study is looking at how long-lasting inflammation in the body might affect people with depression, and it involves giving participants an injection to see how their bodies and brains respond, so we can better understand the connection between inflammation and mental health.
-
Using psilocybin with therapy to treat major depression
This study is looking at how combining psilocybin, a natural psychedelic, with talk therapy can help adults with major depression feel better, and it involves two sessions with psilocybin and 12 therapy sessions to see if this mix works well and is safe.
-
Investigating a new target for treating major depressive disorder using brain imaging
This study is looking at how a brain protein called VAChT might be connected to the severity of major depressive disorder, using special imaging to see its levels in the brain, with the hope of finding new ways to help people with depression.
-
Understanding how genetics and sex affect alcohol use disorders and depression
This study is looking at how our genes might affect problems with alcohol use and depression, especially how these factors differ between men and women, to help improve understanding and treatment for people dealing with these issues.
-
Understanding how brain cells contribute to major depressive disorder
This study is looking at how certain brain cells might be involved in major depressive disorder to help understand the condition better and find new ways to treat it for people who are struggling with depression.
-
The link between gut bacteria and major depressive disorder.
This study is looking at how changes in gut bacteria might affect depression, and it's for people with major depressive disorder who want to understand more about how their gut health could be linked to their mood.
-
Investigating how microRNAs affect major depressive disorder
This study is looking at tiny molecules in the brain that might help explain why some people experience major depressive disorder, with the hope of finding new ways to treat it.
-
Using smartphone and wearable data to track changes in depression symptoms
This study is looking at how smartphone and wearable device data can help track changes in symptoms for people with major depressive disorder, so if you're an adult seeking treatment, you could help us learn more about your mood and behaviors over 90 days to improve personalized care.
-
Using magnetic stimulation to treat depression and pain together
This study is looking at a new way to help people with both depression and chronic pain by using a special treatment called rTMS, which targets different parts of the brain to improve mood and reduce pain.
-
Identifying different types of major depressive disorder using data analysis
This study is looking at different types of major depressive disorder to find better ways to treat people who haven't had success with usual therapies, so they can get more personalized and effective help.
-
Understanding how glutamate metabolism affects major depressive disorder
This study is looking at how a brain chemical called glutamate works in people with depression, hoping to find better ways to treat it with faster-acting medications.
-
Combining esketamine with cognitive behavioral therapy for hospitalized patients with depression and suicidal thoughts
This study is looking at how well combining a fast-acting depression medication called esketamine with talk therapy can help people who are in the hospital because they are feeling suicidal, aiming to see if this mix can improve their mood and keep them safe after they leave.
-
Testing a new brain stimulation technique for teens with suicidal thoughts and depression
This study is looking at a new way to help teenagers who are feeling very depressed and having thoughts of suicide by using a special brain stimulation technique, and it aims to see if this treatment can improve their mood and reduce those thoughts.
-
Combining heat therapy and behavioral therapy to treat major depression
This study is looking at how well a combination of whole-body heating and talk therapy can help people with major depression feel better quickly and improve their mood over time.
-
Investigating brain activity related to memory recall in families with major depression
This study is looking at how the brain reacts when people remember personal experiences to see if it can help predict who might develop depression, especially in young adults with a family history of the condition.
Related topics
Quick answers
How many Depressive Disorder clinical trials are recruiting right now?
45, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 18 countries. The most sites are in United States (11 trials), China (6 trials), Canada (3 trials), Spain (3 trials), Taiwan (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.